Page last updated: 2024-09-02

tamibarotene and bms453

tamibarotene has been researched along with bms453 in 1 studies

Compound Research Comparison

Studies (tamibarotene)	Trials (tamibarotene)	Recent Studies (post-2010) (tamibarotene)	Studies (bms453)	Trials (bms453)	Recent Studies (post-2010) (bms453)
198	10	105	26	0	13

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gronemeyer, H; Kagechika, H; Lou, YR; Miettinen, S; Tuohimaa, P	1

Other Studies

1 other study(ies) available for tamibarotene and bms453

Article	Year
Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells. Biochemical and biophysical research communications, 2005, Dec-30, Volume: 338, Issue:4 Topics: Benzoates; Calcitriol; Cell Line; Cell Line, Tumor; Cells, Cultured; Dibenzazepines; Epithelial Cells; Gene Expression Regulation; Humans; Male; Prostate; Prostatic Neoplasms; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Steroid Hydroxylases; Tetrahydronaphthalenes; Transfection; Tretinoin; Vitamin D3 24-Hydroxylase	2005

Article

Year

Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.

Biochemical and biophysical research communications, 2005, Dec-30, Volume: 338, Issue:4

Topics: Benzoates; Calcitriol; Cell Line; Cell Line, Tumor; Cells, Cultured; Dibenzazepines; Epithelial Cells; Gene Expression Regulation; Humans; Male; Prostate; Prostatic Neoplasms; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Steroid Hydroxylases; Tetrahydronaphthalenes; Transfection; Tretinoin; Vitamin D3 24-Hydroxylase

2005